Cartesian Therapeutics, Inc. - Common Stock — キャッシュフロー (NASDAQ:RNAC) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー 34.88 M-60.38 M-31.63 M-51.16 M-23.67 M-73.94 M -72.97 M 投資活動によるキャッシュフロー -741 K-17.14 M-15 M34.61 M-8.74 M-5.45 M -4.41 M 財務活動によるキャッシュフロー 14.43 M52.9 M39.22 M-13.14 M168.43 M-8.05 M 15.64 M フリーキャッシュフロー 34.88 M-60.38 M-31.63 M-51.16 M-23.67 M-79.39 M -77.37 M

ニュース

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY)

Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates

Cartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BTIGがCartesian Therapeutics株にBuy評価を継続、目標株価44ドル

BTIG reiterates Buy on Cartesian Therapeutics stock, $44 target

Mizuho、治験進展を受けてCartesian Therapeutics株の投資判断を維持

Mizuho reiterates Cartesian Therapeutics stock rating on trial progress

Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Johnson & Johnson Touts Positive Results For Lupus Treatment - Johnson & Johnson (NYSE:JNJ)

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares